You just read:

RegeneRx Announces First Patients Enrolled in Phase 2b/3 U.S. Dry Eye Clinical Trial with RGN-259

News provided by

RegeneRx Biopharmaceuticals, Inc.

Sep 16, 2015, 09:02 ET